Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Net Income (2023 - 2025)

Historic Net Income for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to -$7.0 million.

  • Mereo BioPharma's Net Income rose 5317.65% to -$7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$41.6 million, marking a year-over-year increase of 825.98%. This contributed to the annual value of -$43.3 million for FY2024, which is 4678.95% down from last year.
  • Per Mereo BioPharma's latest filing, its Net Income stood at -$7.0 million for Q3 2025, which was up 5317.65% from -$14.6 million recorded in Q2 2025.
  • In the past 5 years, Mereo BioPharma's Net Income ranged from a high of -$1.8 million in Q2 2023 and a low of -$15.0 million during Q3 2024
  • Its 3-year average for Net Income is -$9.7 million, with a median of -$9.1 million in 2023.
  • Per our database at Business Quant, Mereo BioPharma's Net Income plummeted by 59988.58% in 2024 and then skyrocketed by 5317.65% in 2025.
  • Mereo BioPharma's Net Income (Quarter) stood at -$9.1 million in 2023, then increased by 22.65% to -$7.0 million in 2024, then grew by 0.31% to -$7.0 million in 2025.
  • Its last three reported values are -$7.0 million in Q3 2025, -$14.6 million for Q2 2025, and -$12.9 million during Q1 2025.